dupilumab
sanofi,regeneron
['liberty,eoe,treet', 'eosinophilic,esophagitis']
#dupilumab maintains its safety and efficacy for up to 52 weeks in patients with #eosinophilicesophagitis, according to late-breaking data from the phase 3 liberty eoe treet study presented at #acg2022 #gitwitter 
The content you need, when you need it.